Literature DB >> 8388374

Divergent regulation of phosphatidylinositol 3-kinase P85 alpha and P85 beta isoforms upon T cell activation.

K Reif1, I Gout, M D Waterfield, D A Cantrell.   

Abstract

Phosphatidylinositol (PtdIns) 3-kinase is composed of a catalytic p110 subunit and a regulatory p85 subunit. A synthetic phosphopeptide corresponding to the kinase insert of the human PDGF beta subunit receptor and monoclonal antibodies raised against the two described p85 isoforms, p85 alpha and p85 beta were used to isolate PtdIns 3-kinase from human T lymphocytes. We demonstrate that T cells express both p85 alpha and p85 beta proteins. Both isoforms tightly associate with a p110 protein and with PtdIns 3-kinase activity in T cells. Upon triggering of the T cell antigen receptor (TCR)/CD3 complex or activation of protein kinase C (PKC) the p110 protein complexed to p85 alpha becomes rapidly phosphorylated exclusively on serine residues. p85 alpha does not appear to undergo a change in its basal serine phosphorylation during T cell activation. In contrast, stimulation of the TCR/CD3 complex or PKC, results in a marked and rapid increase in phosphorylation of p85 beta on threonine residues. These data show that PtdIns 3-kinase can be a substrate for serine/threonine kinases in T cells. The differential phosphorylation of p85 alpha and p85 beta reveals the potential for divergent regulation and function of these two PtdIns 3-kinase isoforms during T cell activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388374

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.

Authors:  B Vanhaesebroeck; K Higashi; C Raven; M Welham; S Anderson; P Brennan; S G Ward; M D Waterfield
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation.

Authors:  J Font de Mora; A Porras; N Ahn; E Santos
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking.

Authors:  G A Yudowski; R Efendiev; C H Pedemonte; A I Katz; P O Berggren; A M Bertorello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase.

Authors:  C Jimenez; D R Jones; P Rodríguez-Viciana; A Gonzalez-García; E Leonardo; S Wennström; C von Kobbe; J L Toran; L R-Borlado; V Calvo; S G Copin; J P Albar; M L Gaspar; E Diez; M A Marcos; J Downward; C Martinez-A; I Mérida; A C Carrera
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

5.  Phosphatidylinositol 3-kinase-mediated endocytosis of renal Na+, K+-ATPase alpha subunit in response to dopamine.

Authors:  A V Chibalin; J R Zierath; A I Katz; P O Berggren; A M Bertorello
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

6.  A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis.

Authors:  Zaira García; Virginia Silio; Miriam Marqués; Isabel Cortés; Amit Kumar; Carmen Hernandez; Ana I Checa; Antonio Serrano; Ana C Carrera
Journal:  EMBO J       Date:  2006-10-05       Impact factor: 11.598

7.  The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.

Authors:  P H Stein; J D Fraser; A Weiss
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

Review 8.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

9.  TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.

Authors:  S B Helliwell; P Wagner; J Kunz; M Deuter-Reinhard; R Henriquez; M N Hall
Journal:  Mol Biol Cell       Date:  1994-01       Impact factor: 4.138

10.  The p53 Pathway Encounters the MicroRNA World.

Authors:  Apana Takwi; Yong Li
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.